CTNI-63. PRELIMINARY SAFETY AND EFFICACY OF EMAVUSERTIB (CA-4948) IN COMBINATION WITH IBRUTINIB IN RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS
CTNI-63. EMAVUSERTIB (CA-4948) 联合伊布替尼治疗复发/难治性原发性中枢神经系统淋巴瘤患者的初步安全性和有效性研究
期刊:Postepy W Kardiologii Interwencyjnej
影响因子:1.4
doi:10.5114/pwki.2013.37519
Maciąg, Aleksander; Syska, Paweł; Kuśmierski, Krzysztof; Broy, Beata; Sterliński, Maciej; Nayak, MD, Lakshmi; Dabrowska-Iwanicka, MD, Anna; Tun, MD, Han W; Moustafa, MD, MS, Muhamad Alhaj; Nowakowski, MD, Grzegorz; De La Fuente, MD, Adolfo; Levi, MD, Itai; Grommes, MD, Christian; Lavie, MD, David; Castellino, MD, Alessia; Taszner, MD, Michael; Geethakumari, MD, MS, MBA, Praveen Ramakrishnan; Schenone, MD, Laurence; Ferreri, MD, Andrés J M; Calimeri, MD, Teresa; Nassi, MD, Luca; Houillier, MD, Caroline; Schmitt, MD, Anna; Hernandez-Ilizaliturri, MD, Francisco J; Chauhan, MD, Ayushi; Lane, PhD, Maureen E; Zhou, PhD, Li; Zhao, PhD, Wanying; Ferrari, BS, Dora; Vose, MD, MBA, Julie M; D’Angelo, MD, Christopher R
